Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (81-90 of 1,022) with videos related to

Pageof 103
Sort By:
American Heart Journal|January 13, 2005
Direct thrombin inhibitors: stroke prevention in atrial fibrillation and potential anti-inflammatory propertiesPriya Palagummi, Heath Saltzman, Michael Ezekowitz
The Medical Clinics of North America|September 1, 1995
Contemporary management of atrial fibrillationZ A Ukani, M D Ezekowitz
The New England Journal of Medicine|August 31, 1995
Additional corrections: interferon for hemangiomas of infancyA Ezekowitz, J Mulliken, J Folkman
Annals of Internal Medicine|May 20, 2009
ACP Journal Club. Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fractionJustin A Ezekowitz, Finlay A McAlister
Circulation. Cardiovascular Quality and Outcomes|June 21, 2017
Multitype Events and the Analysis of Heart Failure Readmissions: Illustration of a New Modeling Approach and Comparison With Familiar Composite End PointsPaul M Brown, Justin A Ezekowitz
Circulation. Cardiovascular Quality and Outcomes|June 4, 2018
Examining the Influence of Component Outcomes on the Composite at the Design StagePaul M Brown, Justin A Ezekowitz
The Journal of Gender-Specific Medicine : JGSM : the Official Journal of the Partnership for Women'S Health at Columbia|March 20, 2001
Atrial fibrillation: are there gender differences?H I Michelena, M D Ezekowitz
Immunodeficiency|January 1, 1994
Treatment of chronic granulomatous diseaseR A Seger, R A Ezekowitz
Lancet (London, England)|September 2, 2017
The impact of IMPACT-AFMichael D Ezekowitz, Anthony P Kent
European Journal of Heart Failure|January 5, 2017
Diabetes and heart failure in the crosshairs: where is the target?Justin A Ezekowitz, Paul W Armstrong
Pageof 103

Showing results (81-90 of 1,022) with videos related to

Sort By:
Pageof 103
American Heart Journal|January 13, 2005
Direct thrombin inhibitors: stroke prevention in atrial fibrillation and potential anti-inflammatory propertiesPriya Palagummi, Heath Saltzman, Michael Ezekowitz
The Medical Clinics of North America|September 1, 1995
Contemporary management of atrial fibrillationZ A Ukani, M D Ezekowitz
The New England Journal of Medicine|August 31, 1995
Additional corrections: interferon for hemangiomas of infancyA Ezekowitz, J Mulliken, J Folkman
Annals of Internal Medicine|May 20, 2009
ACP Journal Club. Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fractionJustin A Ezekowitz, Finlay A McAlister
Circulation. Cardiovascular Quality and Outcomes|June 21, 2017
Multitype Events and the Analysis of Heart Failure Readmissions: Illustration of a New Modeling Approach and Comparison With Familiar Composite End PointsPaul M Brown, Justin A Ezekowitz
Circulation. Cardiovascular Quality and Outcomes|June 4, 2018
Examining the Influence of Component Outcomes on the Composite at the Design StagePaul M Brown, Justin A Ezekowitz
The Journal of Gender-Specific Medicine : JGSM : the Official Journal of the Partnership for Women'S Health at Columbia|March 20, 2001
Atrial fibrillation: are there gender differences?H I Michelena, M D Ezekowitz
Immunodeficiency|January 1, 1994
Treatment of chronic granulomatous diseaseR A Seger, R A Ezekowitz
Lancet (London, England)|September 2, 2017
The impact of IMPACT-AFMichael D Ezekowitz, Anthony P Kent
European Journal of Heart Failure|January 5, 2017
Diabetes and heart failure in the crosshairs: where is the target?Justin A Ezekowitz, Paul W Armstrong
Pageof 103